Ten Capital Wealth Advisors, LLC Tyme Technologies, Inc. Transaction History

Ten Capital Wealth Advisors, LLC

  • $341 Million
  • Q2 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022
SELL
$0.23 - $0.35 $1,150 - $1,750
-5,000 Reduced 50.0%
5,000 $1,000
Q1 2022

May 09, 2022
SELL
$0.28 - $0.68 $778 - $1,890
-2,780 Reduced 21.75%
10,000 $4,000
Q1 2021

May 13, 2021
SELL
$1.34 - $3.53 $3,718 - $9,795
-2,775 Reduced 17.84%
12,780 $22,000
Q3 2020

Nov 16, 2020
BUY
$0.93 - $1.35 $14,466 - $20,999
15,555 New
15,555 $15,000

About TYME TECHNOLOGIES, INC.

TYME Quotes by TradingView
  • Ticker TYME
  • Exchange NASDAQ
  • Shares Outstandng 172,207,008
  • Description
  • Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...
More about TYME
Track This Portfolio

Track Ten Capital Wealth Advisors, LLC Portfolio

Follow Ten Capital Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ten Capital Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ten Capital Wealth Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email